Related Experiment Video
Updated: Dec 30, 2025

Characterization of Leukocyte-platelet Rich Fibrin, A Novel Biomaterial
Published on: September 29, 2015
Platelet-rich fibrin prevents postoperative intestinal adhesion
1Department of General Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Abstract:
Platelet-rich fibrin (PRF) was prepared from the blood of BALB/C inbred mice to explore potential effects on postoperative intestinal adhesion. A murine model of intestinal adhesion characterized by abdominal wall defect/and cecum damage was established by scraping caecum serosa and cutting peritoneum and muscles in the abdominal wall. The wound was covered with PRF (group A), sodium hyaluronate (group B), or left alone (blank control; group C). All animals were monitored for 28 days. The incidence of adhesion was 35.0, 66.7, and 73.7% in groups A, B, and C, respectively. The incidence of adhesion in group A was significantly lower than that in group C (p < .05). Histopathologically, severity of fibrosis and the number of fibroblasts or inflammatory cells in group A were lower than those in groups B and C (p < .05), whereas the number of mesothelial cells was higher (p = .001). Furthermore, the severity of fibrosis and number of fibroblasts or inflammatory cells were lower in low grade than those in high grade of adhesion (p < .05), whereas the number of mesothelial cells was higher (p < .05). Collectively, PRF applied to abdominal surgery may reduce the incidence of intestinal adhesion by promoting proliferation of mesothelial cells whereas inhibiting proliferation of fibroblasts and infiltration of inflammatory cells.
Insights
Platelet-rich fibrin (PRF) significantly reduced intestinal adhesion in mice by promoting healing and reducing inflammation. This biomaterial shows promise for preventing postoperative adhesions in abdominal surgery.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Surgical Innovation
Background:
- Postoperative intestinal adhesions are a common complication following abdominal surgery.
- Adhesions can lead to bowel obstruction, infertility, and chronic pain, necessitating further surgical intervention.
- Current prevention strategies have limitations, highlighting the need for novel therapeutic approaches.
Purpose of the Study:
- To investigate the efficacy of platelet-rich fibrin (PRF) in preventing postoperative intestinal adhesions.
- To evaluate the impact of PRF on the histological characteristics of adhesion formation.
- To compare PRF with sodium hyaluronate and a no-treatment control in a murine adhesion model.
Main Methods:
- A murine model of intestinal adhesion was created using abdominal wall defects and cecum damage.
- PRF was applied to the surgical site in the experimental group.
- Control groups received sodium hyaluronate or no treatment; all animals were monitored for 28 days.
Main Results:
- The incidence of intestinal adhesion was significantly lower in the PRF group (35.0%) compared to the control groups (66.7% and 73.7%).
- Histological analysis revealed reduced fibrosis, fewer fibroblasts and inflammatory cells, and increased mesothelial cells in the PRF group.
- A dose-dependent correlation was observed, with lower adhesion severity correlating with improved histological markers.
Conclusions:
- Platelet-rich fibrin demonstrates significant potential in reducing the incidence and severity of postoperative intestinal adhesions.
- PRF may promote healing by enhancing mesothelial cell proliferation while suppressing fibroblast activity and inflammation.
- These findings suggest PRF as a promising biomaterial for preventing intra-abdominal adhesions in surgical settings.
More Related Videos
Related Concept Videos
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Clot Retraction and Fibrinolysis
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Intracellular Signaling Affects Focal Adhesions
Some...

